Case Report
Published on 08 Jun 2023
Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1095737
- 2,478 views
- 1 citation
Type at least 3 characters
933 articles
Articles
Review
Published on 06 Jun 2023
PARP-1: a critical regulator in radioprotection and radiotherapy-mechanisms, challenges, and therapeutic opportunities
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1198948
- 5,553 views
- 6 citations
Original Research
Published on 01 Jun 2023
Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling approaches
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1142003
- 5,055 views
- 4 citations
Correction
Published on 01 Jun 2023
Corrigendum: Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1217008
- 1,061 views
Case Report
Published on 30 May 2023
The dilemma of antibiotic susceptibility and clinical decision-making in a multi-drug-resistant Pseudomonas aeruginosa bloodstream infection
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1183332
- 1,888 views
Original Research
Published on 22 May 2023
Estimation of dihydroartemisinin in human plasma using a highly sensitive LTQ Orbitrap mass spectrometer with Xcalibur software
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1157604
- 1,702 views
- 2 citations
Opinion
Published on 04 May 2023
P-glycoprotein efflux transporter: a key to pharmacokinetic modeling for methadone clearance in fetuses
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1182571
- 1,384 views
- 1 citation
Original Research
Published on 03 May 2023
Oral vinorelbine and continuous low doses of cyclophosphamide in pediatric rhabdomyosarcoma: a real-world study
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1132219
- 3,233 views
- 1 citation
Clinical Trial
Published on 28 Apr 2023
Pharmacokinetics and bioequivalence study of esomeprazole magnesium enteric-coated tablets 20 mg in healthy Chinese subjects under fasting and fed conditions
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1169103
- 7,389 views
Review
Published on 25 Apr 2023
Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1139229
- 9,184 views
- 25 citations
Original Research
Published on 20 Apr 2023
Metformin acts as a dual glucose regulator in mouse brain
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1108660
- 2,520 views
- 2 citations
Original Research
Published on 20 Apr 2023
Fibroblast growth factor 1 ameliorates thin endometrium in rats through activation of the autophagic pathway
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1143096
- 2,848 views
- 1 citation
Clinical Trial
Published on 19 Apr 2023
The effect of JuanBiQiangGu granules in combination with methotrexate on joint inflammation in rheumatoid arthritis: a randomized controlled trial
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1132602
- 1,693 views
- 1 citation
Editorial
Published on 13 Apr 2023
Editorial: Advanced nanotechnological detection and drug delivery configurations
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1198100
- 899 views
Mini Review
Published on 05 Apr 2023
Effects of bariatric surgery on drug pharmacokinetics—Preclinical studies
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1133415
- 8,926 views
- 2 citations
Editorial
Published on 31 Mar 2023
Editorial: Advances in orally inhaled and nasal drug products (OINDPs)
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1185609
- 2,417 views